Literature DB >> 19179329

Eculizumab for congenital atypical hemolytic-uremic syndrome.

Ralph A Gruppo, Russell P Rother.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19179329     DOI： 10.1056/NEJMc0809959

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  97 in total

Review 1.  [Thrombophilic states in intensive care medicine].

Authors:  L Engelmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-28       Impact factor: 0.840

Review 2.  Nephrology research--the past, present and future.

Authors:  Jürgen Floege; Robert H Mak; Bruce A Molitoris; Giuseppe Remuzzi; Pierre Ronco
Journal:  Nat Rev Nephrol       Date:  2015-09-29       Impact factor: 28.314

3.  Atypical HUS caused by anti-complement factor H antibody: a hematologist's perspective.

Authors:  Meet Kumar; Prakas Mandal; Rajib De; Pinaki Mukherjee; Tuphan Kanti Dolai; Maitryee Bhattyacharyya
Journal:  Blood Res       Date:  2015-03-24

Review 4.  Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.

Authors:  Caitlin E Carter; Nadine M Benador
Journal:  Pediatr Nephrol       Date:  2013-06-29       Impact factor: 3.714

Review 5.  Thrombotic microangiopathy with targeted cancer agents.

Authors:  John A Blake-Haskins; Robert J Lechleider; Robert J Kreitman
Journal:  Clin Cancer Res       Date:  2011-08-03       Impact factor: 12.531

Review 6.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

7.  Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab.

Authors:  Kaan Gulleroglu; Kibriya Fidan; Veysel S Hançer; Umut Bayrakci; Esra Baskin; Oguz Soylemezoglu
Journal:  Pediatr Nephrol       Date:  2013-02-07       Impact factor: 3.714

8.  An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome.

Authors:  Sally Johnson; Jelena Stojanovic; Gema Ariceta; Martin Bitzan; Nesrin Besbas; Michelle Frieling; Diana Karpman; Daniel Landau; Craig Langman; Christoph Licht; Carmine Pecoraro; Magdalena Riedl; Ekaterini Siomou; Nicole van de Kar; Johan Vande Walle; Chantal Loirat; C Mark Taylor
Journal:  Pediatr Nephrol       Date:  2014-05-11       Impact factor: 3.714

Review 9.  Advances and challenges in the management of complement-mediated thrombotic microangiopathies.

Authors:  Jean-Claude Davin; Nicole C A J van de Kar
Journal:  Ther Adv Hematol       Date:  2015-08

10.  Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan.

Authors:  Naoko Ito; Hiroshi Hataya; Ken Saida; Yoshiro Amano; Yoshihiko Hidaka; Yaeko Motoyoshi; Toshiyuki Ohta; Yasuhiro Yoshida; Chikako Terano; Tadashi Iwasa; Wataru Kubota; Hidetoshi Takada; Toshiro Hara; Yoshihiro Fujimura; Shuichi Ito
Journal:  Clin Exp Nephrol       Date:  2015-07-09       Impact factor: 2.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.